Latest Period
Q1 2026
Security Snapshot
CRYO CELL INTERNATIONAL INC - Common Stock (CCEL) Institutional Ownership
CUSIP: 228895108
13F Institutional Holders and Ownership History from Q4 2016 to Q2 2026
Institutions Reporting
11
Shares (Excl. Options)
532,695
Price
$3.55
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- CCEL on NYSE
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 532,695
- Total 13F value
- $1,891,110
- Portfolio coverage rank
- 0%
- Share change
- -483,974
- Value change
- -$1,665,955
- Number of holders
- 11
- Shares outstanding
- 8,104,132
- SEC-reported price per share
- $3.19
- Insider filing price
- $3.19
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- CCEL - CRYO CELL INTERNATIONAL INC - Common Stock is tracked under CUSIP 228895108.
- 11 institutions reported positions in Q1 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 11 to 2 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $1,891,110 to $881,509.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 11 institutions filings for Q1 2026.
Security key
228895108
Latest holder period
Q1 2026
13F holders
11
13D/G owners
1
CIK / CUSIP context first
Open Q1 2026 holders
CCEL full holder history
CRYO CELL INTERNATIONAL INC SEC filings
CRYO CELL INTERNATIONAL INC company facts
CRYO CELL INTERNATIONAL INC insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 228895108:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
CCEL
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Camac Partners, LLC | 6.8% | +30% | $1,757,948 | +$383,377 | 551,081 | +28% | Camac Partners, LLC | 02 Jul 2026 |
As of 31 Mar 2026, 11 institutional investors reported holding 532,695 shares of CRYO CELL INTERNATIONAL INC - Common Stock (CCEL). This represents 6.6% of the company’s total 8,104,132 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
39
Latest
Q1 2026
Rows shown
1-25 of 39
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 276,335 | $881,509 | -$355 | $3.19 | 2 |
| 2026 Q1 | 532,695 | $1,891,110 | -$1,665,955 | $3.55 | 11 |
| 2025 Q4 | 982,790 | $3,380,755 | -$31,328 | $3.44 | 16 |
| 2025 Q3 | 988,339 | $4,586,097 | -$60,780 | $4.64 | 20 |
| 2025 Q2 | 996,445 | $5,171,607 | -$226,604 | $5.19 | 20 |
| 2025 Q1 | 1,030,788 | $6,566,178 | -$18,369 | $6.37 | 21 |
| 2024 Q4 | 1,031,296 | $7,642,006 | +$608,027 | $7.41 | 20 |
| 2024 Q3 | 901,345 | $5,741,635 | +$8,650 | $6.37 | 14 |
| 2024 Q2 | 896,630 | $6,823,518 | +$172,576 | $7.61 | 14 |
| 2024 Q1 | 873,958 | $6,520,256 | +$72,530 | $7.46 | 14 |
| 2023 Q4 | 864,332 | $4,969,967 | +$128,357 | $5.75 | 14 |
| 2023 Q3 | 842,009 | $4,429,025 | +$70,615 | $5.26 | 11 |
| 2023 Q2 | 828,572 | $5,038,213 | -$4,153 | $6.08 | 11 |
| 2023 Q1 | 829,343 | $2,504,654 | -$823,499 | $3.02 | 12 |
| 2022 Q4 | 1,023,874 | $4,329,628 | +$1,468,326 | $4.23 | 14 |
| 2022 Q3 | 696,277 | $4,245,000 | -$358,706 | $6.10 | 12 |
| 2022 Q2 | 754,976 | $4,454,000 | -$31,285 | $5.90 | 12 |
| 2022 Q1 | 746,819 | $5,698,000 | -$1,344,734 | $7.63 | 12 |
| 2021 Q4 | 903,450 | $10,130,600 | +$1,014,375 | $11.60 | 11 |
| 2021 Q3 | 650,697 | $7,881,000 | +$6,199,415 | $12.11 | 9 |
| 2021 Q2 | 144,818 | $1,299,000 | +$416,608 | $8.97 | 3 |
| 2021 Q1 | 98,374 | $895,000 | +$203,000 | $9.09 | 2 |
| 2020 Q4 | 76,035 | $585,000 | +$14,888 | $7.69 | 1 |
| 2020 Q3 | 74,100 | $580,000 | $7.83 | 1 | |
| 2020 Q2 | 74,100 | $614,000 | +$55,517 | $8.29 | 1 |